
Tonix Pharmaceuticals Holding Corp (NASDAQ:TNXP) shares are soaring Monday after the World Health Organization (WHO) declared monkeypox a public health emergency of global concern. Tonix's TNX-801 is being developed as a vaccine to protect against monkeypox.
"We already have very compelling data showing protection of monkeys against the lethal challenge of monkeypox," Tonix CEO Seth Lederman said Monday on Benzinga's YouTube show "Stock Market Movers."